U.S., April 2 -- An application to own the trademark for 'LYSVENURE' has been filed on Aug. 27, 2024.
Owner(s):
Genzyme Corporation; 450 Water Street, , Massachusetts
Goods and/or Services:
For: Pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and diseases of the central nervous system; pharmaceutical preparations for the treatment of cancer, thrombosis, and respiratory diseases; pharmaceutical preparations for the treatment of rare diseases, namely, lysosomal storage disorders and autosomal dominant polycystic kidney disease; pharmaceutical preparations for the prevention and treatment of infectious diseases, namely, viral and bacterial infections
Class(es): 005, 006, 018, 044, 046, 051, 052
Mar...